• 2208 Citations
  • 25 h-Index
19972019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Byung Soo Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles
Placenta Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Leucovorin Medicine & Life Sciences
Pluripotent Stem Cells Medicine & Life Sciences
T-Cell Lymphoma Medicine & Life Sciences
Mesenchymal Stromal Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2019

Research Output 1997 2018

  • 2208 Citations
  • 25 h-Index
  • 115 Article
  • 9 Patent
  • 1 Conference contribution
1 Citation (Scopus)

Development and Evaluation of Hyaluronic Acid-Based Hybrid Bio-Ink for Tissue Regeneration

Lee, J., Lee, S. H., Kim, B. S., Cho, Y. S. & Park, Y., 2018 Dec 1, In : Tissue Engineering and Regenerative Medicine. 15, 6, p. 761-769 9 p.

Research output: Contribution to journalArticle

Hyaluronic acid
Tissue regeneration
Ink
Hyaluronic Acid
Regeneration

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma

Kang, K. W., Lee, S. R., Kim, D. S., Yu, E. S., Sung, H. J., Kim, S. J., Choi, C. W., Park, Y. & Kim, B. S., 2018 Feb 1, In : PLoS One. 13, 2, e0192656.

Research output: Contribution to journalArticle

non-Hodgkin lymphoma
computed tomography
Non-Hodgkin's Lymphoma
Tomography
relapse
1 Citation (Scopus)

The derived neutrophil-to-lymphocyte ratio is an independent prognostic factor in transplantation ineligible patients with multiple myeloma

Lee, G. W., Park, S. W., Go, S. I., Kim, H. G., Kim, M. K., Min, C. K., Kwak, J. Y., Bae, S. B., Yoon, S. S., Lee, J. J., Kim, K. H., Nam, S. H., Mun, Y. C., Kim, H. J., Bae, S. H., Shin, H. J., Lee, J. H., Park, J. S., Jeong, S. H., Lee, M. H. & 26 others, Lee, H. S., Park, K. W., Lee, W. S., Lee, S. M., Lee, J. O., Hyun, M. S., Jo, D. Y., Lim, S. N., Lee, J. H., Kim, H., Cho, D. Y., Do, Y. R., Kim, J. A., Park, S. K., Kim, J. S., Kim, S. J., Yi, H. G., Moon, J. H., Choi, C. W., Kim, S. H., Kim, B. S., Park, M. R., Shim, H., Song, M. K., Kim, Y. & Kim, K., 2018 Oct 1, In : Acta Haematologica. 140, 3, p. 146-156 11 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Neutrophils
Transplantation
Lymphocytes
Melphalan
1 Citation (Scopus)

The potential of exosomes derived from chronic myelogenous leukaemia cells as a biomarker

Kang, K. W., Jung, J. H., Hur, W., Park, J., Shin, H., Choi, B., Jeong, H., Kim, D. S., Yu, E. S., Lee, S. R., Sung, H. J., Kim, S. J., Choi, C. W., Kim, H. K., Hong, S., Park, J. H., Choi, Y., Park, Y. & Kim, B. S., 2018 Jul 1, In : Anticancer Research. 38, 7, p. 3935-3942 8 p.

Research output: Contribution to journalArticle

Exosomes
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Biomarkers
RNA Sequence Analysis
Blast Crisis
1 Citation (Scopus)

A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalanprednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma

Kim, M. K., Kim, K., Min, C. K., Kwak, J. Y., Bae, S. B., Yoon, S. S., Lee, J. J., Kim, K. H., Nam, S. H., Mun, Y. C., Kim, H. J., Bae, S. H., Shin, H. J., Lee, J. H., Park, J. S., Jeong, S. H., Lee, M. H., Kim, Y. S., Lee, H. S., Park, K. W. & 24 others, Lee, W. S., Lee, S. M., Lee, J. O., Hyun, M. S., Jo, D. Y., Lim, S. N., Lee, J. H., Cho, D. Y., Do, Y. R., Kim, J. A., Park, S. K., Kim, J. S., Kim, S. J., Kim, H., Yi, H. G., Moon, J. H., Choi, C. W., Kim, S. H., Joo, Y. D., Kim, H. G., Kim, B. S., Park, M. R., Song, M. K. & Kim, S. Y., 2017, In : Oncotarget. 8, 23, p. 37605-37618 14 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Multiple Myeloma
Multicenter Studies
Observational Studies
Safety